JPH0153256B2 - - Google Patents

Info

Publication number
JPH0153256B2
JPH0153256B2 JP55159851A JP15985180A JPH0153256B2 JP H0153256 B2 JPH0153256 B2 JP H0153256B2 JP 55159851 A JP55159851 A JP 55159851A JP 15985180 A JP15985180 A JP 15985180A JP H0153256 B2 JPH0153256 B2 JP H0153256B2
Authority
JP
Japan
Prior art keywords
formula
acid
group
carbon atoms
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP55159851A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5782314A (en
Inventor
Akyoshi Okamoto
Yoshikuni Tamao
Junichi Ooya
Ryoji Kikumoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Chemical Corp
Original Assignee
Mitsubishi Kasei Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Kasei Corp filed Critical Mitsubishi Kasei Corp
Priority to JP55159851A priority Critical patent/JPS5782314A/ja
Publication of JPS5782314A publication Critical patent/JPS5782314A/ja
Publication of JPH0153256B2 publication Critical patent/JPH0153256B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP55159851A 1980-11-13 1980-11-13 Carcinostatic agent Granted JPS5782314A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP55159851A JPS5782314A (en) 1980-11-13 1980-11-13 Carcinostatic agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55159851A JPS5782314A (en) 1980-11-13 1980-11-13 Carcinostatic agent

Publications (2)

Publication Number Publication Date
JPS5782314A JPS5782314A (en) 1982-05-22
JPH0153256B2 true JPH0153256B2 (da) 1989-11-13

Family

ID=15702613

Family Applications (1)

Application Number Title Priority Date Filing Date
JP55159851A Granted JPS5782314A (en) 1980-11-13 1980-11-13 Carcinostatic agent

Country Status (1)

Country Link
JP (1) JPS5782314A (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6431727A (en) * 1987-07-28 1989-02-02 Mitsubishi Chem Ind Dissolution of argininamide and drug composition containing argininamides
CN105637715A (zh) 2013-09-09 2016-06-01 日本航空电子工业株式会社 光电复合连接器及便携式电子设备

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ182812A (en) * 1975-12-09 1984-08-24 Mitsubishi Chem Ind N2-aryl(or aralkyl)sulphonyl-l-argininamides and pharmaceutical compositions
SU1042615A3 (ru) * 1978-08-31 1983-09-15 Мицубиси Кемикал Индастриз Лимитед (Фирма) Способ получени N @ -арил-сульфонил- @ -аргининамидов

Also Published As

Publication number Publication date
JPS5782314A (en) 1982-05-22

Similar Documents

Publication Publication Date Title
JP3140021B2 (ja) Ｔｎｆ阻害剤含有医薬組成物
EP2263694B1 (en) Antitumor agent comprising the histone deacetylase inhibitor FK228 and the topoisomerase II inhibitor doxorubicin
JP4352613B2 (ja) 血管新生促進剤及び血管新生作用増強剤
US20080221145A1 (en) Pyrroloquinoline quinone drugs for treatement of cardiac injury and methods of use thereof
HU227346B1 (en) Process for producing synergetic pharmaceutical composition
JP2002537258A5 (da)
CN115209919A (zh) 慢性心衰的治疗或预防方法
AU712029B2 (en) Use of retinoids for the manufacture of a medicament for the treatment of restenosis
JPH0153256B2 (da)
CN116650490B (zh) 化合物mt-1207在降低尿酸方面的应用
WO1994005290A1 (fr) Inhibiteur d'agregation plaquettaire
JP4525964B2 (ja) 肺高血圧症予防治療剤
HU225113B1 (en) Process for preparation of pharmaceutical compositions for the treatment of vascular deseases containing hydroxylated derivatives of doxazosin
NZ235914A (en) Immunosuppressant pharmaceutical composition
JP3815736B2 (ja) 腫瘍転移抑制剤
JPH03170427A (ja) ピリジニルオキサゾール―２―オン類での多剤耐性腫瘍の処置
JP2004538292A (ja) ナトリウム・カルシウム交換系を阻害する医薬
JPH01503711A (ja) Ｃ‐５モノ置換バルビツレートの尿酸代謝障害を治療するための使用
JP2007536256A (ja) 心臓損傷の処置のためのピロロキノリンキノン薬およびその使用方法
JP4287523B2 (ja) 抗腫瘍剤
JPH0534338B2 (da)
Hosford et al. PAF, cytokines and cell to cell interactions in shock and sepsis
JPH0761931A (ja) 癌転移抑制剤
EP1419767A1 (en) Remedial agent for cardiac failure
JPH0311022A (ja) 薬剤組成物